Moderna (MRNA) Stock Valuation: P/E Ratio and Intrinsic Value
Moderna share price
| Price (USD) | 221.72 |
|---|---|
| Price date | 2026-10-31 |
| Market capitalization | 88.52 USD bn |
Annual and quarterly filings: SEC EDGAR – Moderna
Is Moderna stock expensive or cheap? This page shows the price-earnings ratio of Moderna for the last fiscal years, the current share price, and beta and volatility as risk measures. Earnings figures come from the company's published filings.
How the Moderna P/E ratio is calculated
The price-earnings ratio divides the share price by earnings per share. On this page the ratio is shown per fiscal year, so you can see whether today's valuation of Moderna is above or below its own history. Beta and volatility indicate how strongly the share moves compared with the overall market.
Frequently asked questions about Moderna
What is the MRNA P/E ratio?
The P/E ratio divides the Moderna share price by earnings per share. This page shows the ratio for each of the last fiscal years, so the current valuation of MRNA can be compared with its own history.
Is Moderna stock overvalued or undervalued?
There is no single answer. A useful check is whether the current P/E of MRNA is above or below its multi-year average and how earnings, margins and revenue are developing. This page shows all of these figures from the published filings.
How can I estimate the intrinsic value of Moderna?
An intrinsic value estimate needs earnings or free cash flow, a growth assumption and a discount rate. This page provides the reported earnings basis, margins and the valuation history of MRNA as the starting point.